Effectiveness of the oral human attenuated pentavalent rotavirus vaccine (RotaTeq™) postlicensure: a meta-analysis—2006–2020

References

• Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children <5 Years of Age, 2000-2013. Clin Infect Dis. 2016 May 1;62 Suppl 2(Suppl 2):S96–s105.
   PubMedGoogle Scholar
• Crawford SE, Ramani S, Tate JE, et al. Rotavirus infection. Nat Rev Dis Primers. 2017 Nov;9(3):17083.
   Google Scholar
• Burnett E, Parashar U, Tate J. Rotavirus Vaccines: Effectiveness, Safety, and Future Directions. Paediatric drugs. 2018 Jun;20(3):223–233.
   Google Scholar
• Mahmud-Al-Rafat A, Muktadir A, Muktadir H, et al. Rotavirus epidemiology and vaccine demand: considering Bangladesh chapter through the book of global disease burden. Infection. 2018 Feb;46(1):15–24.
   PubMed Web of Science ®Google Scholar
• Sadiq A, Bostan N, Yinda KC, et al. Rotavirus: genetics, pathogenesis and vaccine advances. Rev Med Virol. 2018 Nov;28(6):e2003.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccinesWHO position paper - january 2013. Releve epidemiologique hebdomadaire. 2013 Feb 01;88(5):49–64.
   PubMedGoogle Scholar
• Parashar UD, Burton A, Lanata C, et al. Global mortality associated with rotavirus disease among children in 2004. J Infect Dis. 2009 Nov 01;200(Suppl s1):S9–s15.
   PubMedGoogle Scholar
• Clark A, Black R, Tate J, et al. Estimating global, regional and national rotavirus deaths in children aged <5 years: current approaches, new analyses and proposed improvements. PloS One. 2017;12(9):e0183392.
   PubMed Web of Science ®Google Scholar
• Fu C, Wang M, Liang J, et al. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine. 2007 Dec 17;25(52):8756–8761.
   PubMed Web of Science ®Google Scholar
• Goveia MG, Rodriguez ZM, Dallas MJ, et al. Safety and efficacy of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy premature infants. Pediatr Infect Dis J. 2007 Dec;26(12):1099–1104.
   PubMed Web of Science ®Google Scholar
• Dang DA, Nguyen VT, Vu DT, et al. A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children. Vaccine. 2012 Apr 27;30(Suppl 1):A114–21.
   PubMed Web of Science ®Google Scholar
• John J, Kawade A, Rongsen-Chandola T, et al. Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India. Vaccine. 2014 Aug 11;32(Suppl 1):A104–9.
   PubMed Web of Science ®Google Scholar
• Naik SP, Zade JK, Sabale RN, et al. Stability of heat stable, live attenuated Rotavirus vaccine (ROTASIIL(R)). Vaccine. 2017 May 19;35(22):2962–2969.
   PubMed Web of Science ®Google Scholar
• Sultana M, Mahumud RA, Van Der Meer R, et al. ROTAVAC((R)) does not interfere with the immune response to childhood vaccines in Indian infants: a randomized placebo controlled trial. Hum Vaccin Immunother. 2017 May;3(5):e00302.
   Google Scholar
• Willame C, Vonk Noordegraaf-Schouten M, Gvozdenović E, et al. Effectiveness of the oral human attenuated rotavirus vaccine: a systematic review and meta-analysis-2006-2016. Open Forum Infect Dis. 2018 Nov 5;5(11):ofy292.
   PubMed Web of Science ®Google Scholar
• Folorunso OS, Sebolai OM. Overview of the development, impacts, and challenges of live-attenuated oral rotavirus vaccines. Vaccines (Basel). 2020 Jun 27;8(3):3.
   Web of Science ®Google Scholar
• Soares-Weiser K, Bergman H, Henschke N, et al. Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev. 2019 Oct 28;2019(10):10.
   Google Scholar
• Bernstein D. Efficacy of the pentavalent rotavirus vaccine in subjects after 1 or 2 doses in the rotavirus efficacy and safety trial. Pediatrics. 2008 Jan;121(1):223. 223; author reply.
   Web of Science ®Google Scholar
• Chang WC, Yen C, Wu FT, et al. Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants. Pediatr Infect Dis J. 2014 Mar;33(3):e81–6.
   PubMed Web of Science ®Google Scholar
• Rha B, Tate JE, Payne DC, et al. Effectiveness and impact of rotavirus vaccines in the United States - 2006-2012. Expert Rev Vaccines. 2014 Mar;13(3):365–376.
   PubMed Web of Science ®Google Scholar
• Payne DC, Selvarangan R, Azimi PH, et al. Long-term consistency in rotavirus vaccine protection: RV5 and RV1 vaccine effectiveness in US children, 2012-2013. Clin Infect Dis. 2015 Dec 15;61(12):1792–1799.
   PubMed Web of Science ®Google Scholar
• Gastañaduy PA, Contreras-Roldán I, Bernart C, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in guatemala. Clin Infect Dis. 2016 May 1;62(Suppl 2):S121–6.
   PubMedGoogle Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clin Infect Dis. 2016 May 1;62(Suppl 2):S127–32.
   PubMedGoogle Scholar
• Hemming-Harlo M, Vesikari T, Uhari M, et al. Sustained high effectiveness of rotateq on hospitalizations attributable to rotavirus-associated gastroenteritis during 4 years in Finland. J Pediatric Infect Dis Soc. 2017 Nov 24;6(4):317–323.
   PubMed Web of Science ®Google Scholar
• Muhsen K, Anis E, Rubinstein U, et al. Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study. Clin Microbiol Infect. 2018 Jan;24(1):53–59.
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, et al. Effectiveness of Rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006-2016. Clin Infect Dis. 2017 Sep 1;65(5):840–850.
   PubMed Web of Science ®Google Scholar
• Pindyck T, Tate JE, Parashar UD. A decade of experience with rotavirus vaccination in the United States - vaccine uptake, effectiveness, and impact. Expert Rev Vaccines. 2018 Jul;17(7):593–606.
   PubMed Web of Science ®Google Scholar
• Leshem E, Tate JE, Steiner CA, et al. National estimates of reductions in acute gastroenteritis-related hospitalizations and associated costs in us children after implementation of rotavirus vaccines. J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):257–260.
   PubMed Web of Science ®Google Scholar
• Hallowell BD, Parashar UD, Curns A, et al. Trends in the laboratory detection of rotavirus before and after implementation of routine rotavirus vaccination - United States, 2000-2018. MMWR Morb Mortal Wkly Rep. 2019 Jun 21;68(24):539–543.
   PubMed Web of Science ®Google Scholar
• Mwenda JM, Parashar UD, Cohen AL, et al. Impact of rotavirus vaccines in sub-saharan African countries. Vaccine. 2018 Nov 12;36(47):7119–7123.
   PubMedGoogle Scholar
• Aliabadi N, Antoni S, Mwenda JM, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008-16: findings from the global rotavirus surveillance network. Lancet Glob Health. 2019 Jul 7;7(7):e893–e903.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010 Aug 21;376(9741):606–614.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010 Jan 28;362(4):289–298.
   PubMed Web of Science ®Google Scholar
• Moon SS, Wang Y, Shane AL, et al. Inhibitory effect of breast milk on infectivity of live oral rotavirus vaccines. Pediatr Infect Dis J. 2010 Oct;29(10):919–923.
   PubMed Web of Science ®Google Scholar
• Zaman K, Dang DA, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010 Aug 21;376(9741):615–623.
   PubMed Web of Science ®Google Scholar
• Patel M, Steele AD, Parashar UD. Influence of oral polio vaccines on performance of the monovalent and pentavalent rotavirus vaccines. Vaccine. 2012 Apr 27;30(Suppl 1):A30–5.
   PubMed Web of Science ®Google Scholar
• Taniuchi M, Platts-Mills JA, Begum S, et al. Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants. Vaccine. 2016 Jun 8;34(27):3068–3075.
   PubMed Web of Science ®Google Scholar
• Desselberger U. Differences of rotavirus vaccine effectiveness by country: likely causes and contributing factors. Pathogens. 2017 Dec 12;6(4):4.
   Web of Science ®Google Scholar
• Harris VC, Armah G, Fuentes S, et al. Significant correlation between the infant gut microbiome and rotavirus vaccine response in rural ghana. J Infect Dis. 2017 Jan 1;215(1):34–41.
   PubMed Web of Science ®Google Scholar
• Harris V, Ali A, Fuentes S, et al. Rotavirus vaccine response correlates with the infant gut microbiota composition in Pakistan. Gut Microbes. 2018 Mar 4;9(2):93–101.
   PubMed Web of Science ®Google Scholar
• Parker EP, Ramani S, Lopman BA, et al. Causes of impaired oral vaccine efficacy in developing countries. Future Microbiol. 2018 Jan;13(1):97–118.
   PubMed Web of Science ®Google Scholar
• Wells BS GA, O’Connell D, Peterson J, et al. The newcastle-ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. University of Ottawa. [Internet]. (2015). [cited 2020 Oct 10]. Available from:http://www.ohri.ca/programs/clinical_epidemiology/nosgen.pdf
   Google Scholar
• Rid A, Saxena A, Baqui AH, et al. Placebo use in vaccine trials: recommendations of a WHO expert panel. Vaccine. 2014 Aug 20;32(37):4708–4712.
   PubMed Web of Science ®Google Scholar
• McLean HQ, Belongia EA. Influenza vaccine effectiveness: new insights and challenges. Cold Spring Harb Perspect Med. 2020 Jan 27; a038315. 10.1101/cshperspect.a038315
   PubMed Web of Science ®Google Scholar
• De Serres G, Skowronski DM, Wu XW, et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill. 2013 Sep 12;18(37):37.
   Google Scholar
• Ruuska T, Vesikari T, Delem A, et al. Evaluation of RIT 4237 bovine rotavirus vaccine in newborn infants: correlation of vaccine efficacy to season of birth in relation to rotavirus epidemic period. Scand J Infect Dis. 1990;22(3):269–278.
   PubMed Web of Science ®Google Scholar
• Gauvreau KP. Marcello. principles of biostatistics. 2 ed. ed. Boca Raton: CRC Press; 2018.
   Google Scholar
• Fang J. Medical statistics. 3 ed.. China: People’s Medical Publishing House Co., LTD; 2013.
   Google Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua. Jama. 2009 Jun 3;14(2):2243–2251.
   Google Scholar
• Boom JA, Tate JE, Sahni LC, et al. Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States. Pediatrics. 2010 Feb;125(2):e199–207.
   PubMed Web of Science ®Google Scholar
• Field EJ, Vally H, Grimwood K, et al. Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia. Pediatrics. 2010 Sep;126(3):e506–12.
   PubMed Web of Science ®Google Scholar
• Sahni LC, Boom JA, Patel MM, et al. Use of an immunization information system to assess the effectiveness of pentavalent rotavirus vaccine in US children. Vaccine. 2010 Aug 31;28(38):6314–6317.
   PubMed Web of Science ®Google Scholar
• Cortese MM, Leblanc J, White KE, et al. Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine. Pediatrics. 2011 Dec;128(6):e1474–81.
   PubMed Web of Science ®Google Scholar
• Guh AY, Hadler JL. Use of the state immunization information system to assess rotavirus vaccine effectiveness in Connecticut, 2006-2008. Vaccine. 2011 Aug 26;29(37):6155–6158.
   PubMed Web of Science ®Google Scholar
• Martinon-Torres F, Alejandro MB, Collazo LR, et al. Effectiveness of rotavirus vaccination in Spain. Hum Vaccines. 2011 Jul;7(s1):757–761.
   PubMedGoogle Scholar
• Mast TC, Khawaja S, Espinoza F, et al. Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua. Pediatr Infect Dis J. 2011 Nov;200(s1):e209–15.
   Google Scholar
• Staat MA, Payne DC, Donauer S, et al. Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics. 2011 Aug;128(2):e267–75.
   PubMed Web of Science ®Google Scholar
• Castilla J, Beristain X, Martinez-Artola V, et al. Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain. Vaccine. 2012 Jan;30(3):539–543.
   PubMed Web of Science ®Google Scholar
• Cortese MM, Immergluck LC, Held M, et al. Effectiveness of monovalent and pentavalent rotavirus vaccine. Pediatrics. 2013 Jul;132(1):e25–33.
   PubMed Web of Science ®Google Scholar
• Donauer S, Payne DC, Edwards KM, et al. Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs. Vaccine. 2013 May 31;31(24):2692–2697.
   PubMed Web of Science ®Google Scholar
• Payne DC, Boom JA, Staat MA, et al. Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis. 2013 Jul;57(1):13–20.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Uhari M, Renko M, et al. Impact and effectiveness of RotaTeq(R) vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland. Pediatr Infect Dis J. 2013 Dec;32(12):1365–1373.
   PubMed Web of Science ®Google Scholar
• Marlow R, Ferreira M, Cordeiro E, et al. Case control study of rotavirus vaccine effectiveness in Portugal during 6 years of private market use. Pediatr Infect Dis J. 2015 May;34(5):509–512.
   PubMed Web of Science ®Google Scholar
• Perez-Vilar S, Diez-Domingo J, Lopez-Lacort M, et al. Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the valencia region, Spain. BMC Infect Dis. 2015 Feb 25;15(1):92.
   PubMedGoogle Scholar
• Gastanaduy PA, Contreras-Roldan I, Bernart C, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in guatemala. Clin Infect Dis. 2016 May 1;62(Suppl 2):S121–6.
   PubMedGoogle Scholar
• Immergluck LC, Parker TC, Jain S, et al. Sustained effectiveness of monovalent and pentavalent rotavirus vaccines in children. J Pediatr. 2016 May;172(116):116–120.e1.
   PubMedGoogle Scholar
• Leshem E, Givon-Lavi N, Tate JE, et al. Real-world effectiveness of pentavalent rotavirus vaccine among bedouin and jewish children in Southern Israel. Clin Infect Dis. 2016 May 1;62(Suppl 2):S155–60.
   PubMedGoogle Scholar
• Tate JE, Ngabo F, Donnen P, et al. Effectiveness of pentavalent rotavirus vaccine under conditions of routine use in rwanda. Clin Infect Dis. 2016 May 1;62(Suppl 2):S208–12.
   PubMedGoogle Scholar
• Araki K, Hara M, Tsugawa T, et al. Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children. Vaccine. 2018 Aug 16;36(34):5187–5193.
   PubMed Web of Science ®Google Scholar
• Bonkoungou IJO, Aliabadi N, Leshem E, et al. Impact and effectiveness of pentavalent rotavirus vaccine in children <5years of age in Burkina Faso. Vaccine. 2018 Nov 12;36(47):7170–7178.
   PubMedGoogle Scholar
• Fathima P, Tl S, Gibbs RA. Effectiveness of rotavirus vaccines in an Australian population: a case-control study. Vaccine. 2019 Sep 24;37(41):6048–6053.
   PubMed Web of Science ®Google Scholar
• World bank list of economies. [internet]. (2015). [cited 2020 Oct 10]. Available from: https://stats.areppim.com/archives/guide_WB_list_economies_2015.pdf
   Google Scholar
• Hungerford D, Smith K, Tucker A, et al. Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies. BMC Infect Dis. 2017 Aug 15;17(1):569.
   PubMed Web of Science ®Google Scholar
• Burnett E, Parashar UD, Tate JE. Real-world effectiveness of rotavirus vaccines, 2006-19: a literature review and meta-analysis. Lancet Glob Health. 2020 Sep;8(9):e1195–e1202.
   PubMed Web of Science ®Google Scholar
• Breiman RF, Zaman K, Armah G, et al. Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine. Vaccine. 2012 Apr 27;30(Suppl 1):A24–9.
   PubMed Web of Science ®Google Scholar
• Grant LR, Watt JP, Weatherholtz RC, et al. Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children. Pediatr Infect Dis J. 2012 Feb;31(2):184–188.
   PubMed Web of Science ®Google Scholar
• Tapia MD, Armah G, Breiman RF, et al. Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa. Vaccine. 2012 Apr 27;30(Suppl 1):A79–85.
   PubMedGoogle Scholar
• Iwata S, Nakata S, Ukae S, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother. 2013 Aug;9(8):1626–1633.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Karvonen A, Prymula R, et al. Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study. Lancet. 2007 Nov 24;370(9601):1757–1763.
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009 Oct 9;27(43):5936–5941.
   PubMed Web of Science ®Google Scholar
• Cunliffe NA, Witte D, Ngwira BM, et al. Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial. Vaccine. 2012 Apr 27;30(Suppl 1):A36–43.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Kirsten M, Louw C, et al. Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: a randomized, double-blind, placebo-controlled trial. Vaccine. 2012 Apr 27;30(Suppl 1):A44–51.
   PubMed Web of Science ®Google Scholar
• Abou-Nader AJ, Sauer MA, Steele AD, et al. Global rotavirus vaccine introductions and coverage: 2006-2016. Hum Vaccin Immunother. 2018;14(9):2281–2296.
   PubMed Web of Science ®Google Scholar
• Deen J, Lopez AL. Improving rotavirus vaccine coverage: can newer-generation and locally produced vaccines help? Hum Vaccin Immunother.2018 Feb 1;14(2):495–499.
   Google Scholar
• Carvalho MF, Gill D. Rotavirus vaccine efficacy: current status and areas for improvement. Hum Vaccin Immunother. 2019;15(6):1237–1250.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006 Jan 5;354(1):11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006 Jan 05;354(1):23–33.
   PubMed Web of Science ®Google Scholar